Timing, Fundamentals, and Diversification of SurgePays Inc. (SURG)

The closing price of SurgePays Inc. (NASDAQ: SURG) was $6.05 for the day, up 3.77% from the previous closing price of $5.83. In other words, the price has increased by $+0.22 from its previous closing price. On the day, 128630 shares were traded. SURG stock price reached its highest trading level at $6.10 during the session, while it also had its lowest trading level at $5.89.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.

Sponsored

Ratios:

Our analysis of SURG’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 0.60 and its Current Ratio is at 1.00. In the meantime, Its Debt-to-Equity ratio is 22.33 whereas as Long-Term Debt/Eq ratio is at 9.33.

Upgrades & Downgrades

Insider Transactions:

Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Aug 31 when Cox Kevin Brian bought 5,000 shares for $4.30 per share. The transaction valued at 21,500 led to the insider holds 3,452,694 shares of the business.

Cox Kevin Brian bought 7,000 shares of SURG for $33,360 on Aug 18. The CHIEF EXECUTIVE OFFICER now owns 3,449,694 shares after completing the transaction at $4.77 per share. On Jun 03, another insider, Mott John, who serves as the CHIEF TECHNOLOGY OFFICER of the company, bought 500 shares for $4.53 each. As a result, the insider paid 2,265 and bolstered with 9,788 shares of the company.

Valuation Measures:

For the stock, the TTM Price-to-Sale (P/S) ratio is 0.92 while its Price-to-Book (P/B) ratio in mrq is 118.63.

Stock Price History:

Over the past 52 weeks, SURG has reached a high of $7.30, while it has fallen to a 52-week low of $1.76. The 50-Day Moving Average of the stock is 5.29, while the 200-Day Moving Average is calculated to be 4.57.

Shares Statistics:

SURG traded an average of 116.49K shares per day over the past three months and 154.83k shares per day over the past ten days. A total of 12.41M shares are outstanding, with a floating share count of 7.92M. Insiders hold about 27.90% of the company’s shares, while institutions hold 8.20% stake in the company. Shares short for SURG as of Oct 13, 2022 were 1.3M with a Short Ratio of 1.40M, compared to 1.17M on Sep 14, 2022. Therefore, it implies a Short% of Shares Outstanding of 10.46% and a Short% of Float of 15.83%.

Earnings Estimates

The firm’s stock currently is rated by 2 analysts. The consensus estimate for the next quarter is $0.78, with high estimates of $0.88 and low estimates of $0.68.

Analysts are recommending an EPS of between $1.02 and $0.8 for the fiscal current year, implying an average EPS of $0.91. EPS for the following year is $2.4, with 2 analysts recommending between $2.91 and $1.9.

Revenue Estimates

A total of 2 analysts have provided revenue estimates for SURG’s current fiscal year. The highest revenue estimate was $130M, while the lowest revenue estimate was $124.24M, resulting in an average revenue estimate of $127.12M. In the same quarter a year ago, actual revenue was $51.06M, up 149.00% from the average estimate. Based on 2 analysts’ estimates, the company’s revenue will be $189.84M in the next fiscal year. The high estimate is $200M and the low estimate is $179.68M. The average revenue growth estimate for next year is up 49.30% from the average revenue estimate for this year.